Galaxy Medisolutions Private Limited

Galaxy Medisolutions Private Limited - real estate and construction in Delhi, India. FY 2026 financials & compliance.
CIN U85100DL2013PTC250085 Incorporated 30 March 2013 ROC Delhi HQ Delhi, India
Active Private Limited Company real estate and construction
Data last updated
Revenue · FY 2025
₹36,409
▼ 75% YoY
Net loss · FY 2025
₹4.75 Lakh
Latest filing
EBITDA · FY 2025
-₹3.98 Lakh
Latest filing
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹3.21 Cr
Issued & subscribed
Satisfied charges
₹35 Cr
No open charges
Company age
13 yrs
Est. 2013
Employees · EPFO
3
Provident fund records

About Galaxy Medisolutions Private Limited

Data last updated:

Galaxy Medisolutions Private Limited is a private limited company based in Delhi, India. It operates in the real estate development and construction segment of the real estate and construction sector. It was incorporated on 30 March 2013 and has been in existence for over 13 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2013PTC250085.

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.21 Cr. It is led by directors including Rashmi Agarwal and Arun Kumar Agrawal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No. 105 First Floor Vardhman'S Sidhant – Shopping Plaza Lsc Savita Vihar, Delhi, India – 110092.

As per the financials filed for FY 2025, the company reported a revenue of ₹36,409, a decline of 75% compared to the previous year. For the same year it recorded a net loss of ₹4.75 Lakh and EBITDA of -₹3.98 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 77% over three years and 75% over five years.

The company has about 3 employees on its provident fund (EPFO) records.

As per MCA filings, the company has satisfied charges of ₹35 Cr on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U85100DL2013PTC250085
Registration Number 250085
Incorporation Date 30 March 2013
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Galaxy Medisolutions Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Unit No. 105 First Floor Vardhman'S Sidhant – Shopping Plaza Lsc Savita Vihar, Delhi, India – 110092
  • Industry
    Real Estate and Construction, Real Estate Builders & Developers

To see the full contact details of Galaxy Medisolutions Private Limited, buy the company report.

Comprehensive company report
Galaxy Medisolutions Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Galaxy Medisolutions Private Limited

FY 2025 filings available

Galaxy Medisolutions Private Limited reported revenue of ₹36,409 (down 75% YoY) for FY 2025.

Revenue · FY 2025
₹36,409 ▼ 75%
Net loss · FY 2025
₹4.75 Lakh
EBITDA · FY 2025
-₹3.98 Lakh

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 75%
3 years · compounded
▼ 77%
5 years · compounded
▼ 75%
EBITDA CAGR growth
1 year
▲ 6%
3 years · compounded
▼ 29%
5 years · compounded
▼ 16%

Revenue has declined at a compounded annual rate (CAGR) of 75% over five years, including a 75% fall in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹3.98 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹4.75 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Galaxy Medisolutions Private Limited, buy the company report.

Board of directors of Galaxy Medisolutions Private Limited

Galaxy Medisolutions has 4 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rashmi AgarwalDirector31 May 20224 Years 4 MonthsCurrent
Arun Kumar AgrawalDirector31 May 20224 Years 4 MonthsCurrent
Pranati SharmaDirector31 May 20224 Years 4 MonthsCurrent
Abhishek AgrawalDirector31 May 20224 Years 4 MonthsCurrent

Auditor

Galaxy Medisolutions Private Limited is audited by DARPN and Company for the financial year 2023.

Auditor firmFinancial yearFirm registration number
DARPN and CompanyFY 2023016790C

Shareholding

The shareholding of Galaxy Medisolutions Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Galaxy Medisolutions Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹35 Cr
Breakdown by lending institutions
Syndicate Bank₹35.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
19 Feb 201610621416Syndicate Bank₹20 CrSatisfied
30 Dec 201410539000Syndicate Bank₹15 CrSatisfied

To see the full charge records of Galaxy Medisolutions Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Galaxy Medisolutions Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Galaxy Medisolutions Private Limited has a workforce of 3 employees on its EPFO records as of May 20, 2024, across 1 active EPFO establishment.

Employee count
3
Active EPFO establishments
1
Employee growth
50%

GST

No GST registration is on our record for Galaxy Medisolutions Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Galaxy Medisolutions Private Limited has 15 board changes on record since 2015: 4 appointments and 11 cessations. The latest: Abhishek Agrawal ceased to be Additional Director on 30 Sep 2022.

AGM
Galaxy Medisolutions Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Galaxy Medisolutions Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Abhishek Agrawal ceased to be Additional Director.
Ceased
Arun Kumar Agrawal ceased to be Additional Director.
Ceased
Pranati Sharma ceased to be Additional Director.
Ceased
Rashmi Agarwal ceased to be Additional Director.
Ceased
Pradeep Kumar Agrawalla ceased to be Director.
Ceased
Mukesh Kumar Agarwal ceased to be Director.
Appointed
Abhishek Agrawal was appointed as Director.
Appointed
Arun Kumar Agrawal was appointed as Director.
Appointed
Pranati Sharma was appointed as Director.
Appointed
Rashmi Agarwal was appointed as Director.

10 earlier events are in the company report.

Frequently asked questions

Galaxy Medisolutions is an active private limited company based in Delhi, India. The company works in real estate builders and developers, within the real estate and construction industry. It was incorporated on 30 March 2013 (13+ years old) and is registered under CIN U85100DL2013PTC250085.

Galaxy Medisolutions has 4 current directors:

The latest financial statements of Galaxy Medisolutions on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Galaxy Medisolutions is U85100DL2013PTC250085. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Galaxy Medisolutions has 1 court case on record: 1 filed by the company. 1 is pending.

Galaxy Medisolutions was incorporated on 30 March 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.

Abhishek Agrawal ceased to be Additional Director on 30 Sep 2022. Arun Kumar Agrawal ceased to be Additional Director on 30 Sep 2022. Pranati Sharma ceased to be Additional Director on 30 Sep 2022. Galaxy Medisolutions has 15 board changes on record in total.

The registered office of Galaxy Medisolutions is at Unit No. 105 First Floor VardhmanS Sidhant – Shopping Plaza Lsc Savita Vihar, Delhi, India – 110092.

Galaxy Medisolutions operates in the real estate and construction industry, in the real estate builders and developers segment.

Galaxy Medisolutions has no open charges and satisfied charges of ₹35 Cr as per latest MCA filings.